
Researchers develop breakthrough Covid-19 vaccine
Needle-free nano-vaccine, cheap to produce, requires no refrigeration and is administered as nasal spray, making it accessible to developing nations.

Needle-free nano-vaccine, cheap to produce, requires no refrigeration and is administered as nasal spray, making it accessible to developing nations.

First study of its kind monitored physiological data of nearly 5,000 Israelis for two years, finding no unusual adverse events.

Sheba Pandemic Research Institute to focus on multidisciplinary, collaborative infectious disease R&D of clinical products for emergency deployment.

Study published in New England Journal of Medicine demonstrates significant increase in protection from third and fourth doses, but it wanes quickly.

Researchers in Israel find that antibodies from recovered Covid-19 patients can neutralize all known strains of the virus, including Delta and Omicron.

Vaccine candidate to be given to volunteers at start and two months later to study duration of immunity and effectiveness of the immune system.

Death due to Covid-19 was 78% lower among adults 60-100 who got a second booster of the Covid-19 vaccine, reveals study by Clalit Health Services.

Sheba Medical Center set to enroll first study outside of US to test new formulation against Omicron and other emerging variants.

Women reportedly suffer more from arm pain, headaches and weakness following the Pfizer-BioNTech vaccine, but scientists unsure of mechanism involved.

Yes, immunity may be stronger after recovery from the disease, but medical experts strongly advise against intentional exposure. Here’s why.

New data suggests second booster increases protection against infection by about 2 times compared to first booster.

First-in-world preliminary findings: Second booster with Pfizer or Moderna raises antibodies but not enough to protect against Omicron Covid variant.

Eli Bin, head of the national emergency response group, joins managers pitching in across Israel due to the unprecedented testing demand.

Israel was the first country in the world to authorize a third and fourth dose. Pioneering is central to this country’s DNA. I don’t mind being a guinea pig if it means keeping myself and my loved ones safe.

World’s first clinical trial of 4th Pfizer dose will see if Moderna impacts protection from previous Pfizer shots. Meanwhile, US FDA okays booster in kids based on Israeli data.